The Effects of Solriamfetol and CBT-I (alone and in combination) on Sleep Continuity Sleepiness Fatigue and Performance in Patients with Insomnia Disorder
Recruiting
99 years and younger
All
60 participants needed
1 Location
Brief description of study
PURPOSE:
The objective of this project is to test the efficacy of solriamfetol for treating insomnia (alone and in combination with CBT-I). Ultimately, this study will test whether wake extension (regardless of how it is achieved) will consolidate sleep and improve sleep continuity. Patients administered solriamfetol will have significantly greater improvements in sleep continuity (total wake time [TWT]) from baseline to post-treatment compared to patients administered placebos. Note: the study is powered for this hypothesis. 1. Patients treated with CBT-I will have significantly greater improvements in sleep continuity from baseline to post-treatment compared to patients not administered CBT-I.
2. Patients treated with CBT-I in combination with solriamfetol with have significantly greater improvements in sleep continuity from baseline to post-treatment compared to patients treated with CBT-I alone.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
Updated on
14 Jun 2023.
Study ID: 850945
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
